Literature DB >> 2343138

Tumorectomy and radiation therapy in early breast cancer: a report on 392 patients.

J B Dubois1, M Saumon-Reme, J Gary-Bobo, H Pourquier, H Pujol.   

Abstract

Three hundred ninety-two breast cancer patients (231 with stage I and 161 with stage II disease) were treated with tumorectomy followed by radiation therapy. The overall actuarial survival rate was 86.5% at 5 years and 78.0% at 10 years. The 5-year disease-free survival rate was 70.2%. Survival rates depended on locoregional tumor extension. Patients with stage I tumors had a survival rate of 92.0% at 5 years and 84.0% at 10 years; patients with stage II tumors had a survival rate of 82.0% at 5 years and 75.0% at 10 years. The percentage of patients with local recurrences was 13.0% for all patients (10.8% for stage I and 16.1% for stage II patients). The percentage of patients with lymph node recurrences was 1.5% for all patients (1.3% for stage I and 1.9% for stage II patients). The percentage of patients with distant metastases was 11.2% for all patients (7.8% for stage I and 16.1% for stage II patients). Locoregional control rates compared favorably with those in the literature. Breast preservation rates at 5 years were 85.0% for stage I and 80.9% for stage II patients. Cosmetic results were judged good by physicians in 80% of patients and by 90% of the patients themselves. Complication rates were very low.

Entities:  

Mesh:

Year:  1990        PMID: 2343138     DOI: 10.1148/radiology.175.3.2343138

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  2 in total

1.  Local Control and Cosmetic Outcome after Sector Resection with or without Radiation Therapy for Early Breast Cancer.

Authors: 
Journal:  Breast Cancer       Date:  1996-03-29       Impact factor: 4.239

2.  An analysis of breast cancer in Hungary: experience of the National Institute of Oncology, Budapest.

Authors:  I Besznyák; E Svastics
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.